HARPOON THERAPEUTICS INC (HARP)

US41358P2056 - Common Stock

23.01  +0.02 (+0.09%)

After market: 23 -0.01 (-0.04%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
17.44M
201.73%		23.65M
35.61%		31.92M
34.97%		38.812M
21.59%
EBITDA
YoY % growth
-49.25M
14.06%		-64.61M
-31.19%		-65.97M
-2.10%		-35.986M
45.45%		N/AN/AN/AN/AN/A
EBIT
YoY % growth
-51.33M
11.82%		-66.8M
-30.14%		-68.33M
-2.29%		-33.496M
50.98%
Operating Margin
-294.32%-282.45%-214.07%-86.30%
EPS
YoY % growth
-2.00
24.24%		-2.06
-3.00%		-20.50
-895.15%		-2.04
90.06%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 23 Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24
EPS
Q2Q % growth		-0.65
88.18%
Revenue
Q2Q % growth		5.715M
39.73%
EBITDA
Q2Q % growth		-16.459MN/A
EBIT
Q2Q % growth		-11.409M
39.02%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2023
Q2Q % growth		 -0.46
86.86%		-3.262.8085.90%
Q2 2023
Q2Q % growth		 0.30
105.66%		-3.483.78108.62%
Q1 2023
Q2Q % growth		 -3.10
50.00%		-3.910.8120.72%
Q4 2022
Q2Q % growth		 -5.50
-733.33%		-4.76-0.74-15.50%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2023
Q2Q % growth		 4.45M
-67.33%		4.311M139K3.22%
Q2 2023
Q2Q % growth		 20.22M
143.61%		5.251M14.969M285.07%
Q1 2023
Q2Q % growth		 8.58M
45.18%		4.906M3.674M74.89%
Q4 2022
Q2Q % growth		 4.09M
-5.54%		7.184M-3.094M-43.07%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -0.01% 0% 25.31%
Revenue0% 6.92% 0% -1.24%